Strategic Fit Position Function Oncology as a precision medicine partner leveraging CRISPR-powered functional genomics to tailor cancer therapies, offering potential collaboration with biotech firms and pharma seeking patient-specific drug development and biomarker-led trial design.

Clinical Differentiation Highlight the unique value proposition of measuring gene function beyond sequencing to identify optimal therapeutic opportunities, creating opportunities to engage academic centers, contract research organizations, and cancer clinics aiming to improve trial enrichment and treatment outcomes.

Tech Enablement Leverage the cloud and modern web stack (AWS, Node.js, Nuxt.js) to propose scalable data analytics and secure datasets collaborations with enterprise biology platforms, CROs, and health-tech integrators seeking robust, compliant genomics tools.

Growth Signals Note the small team size and San Diego biotech presence as an entry point for regional partnerships, pilot programs, and grant-funded collaborations with universities or incubators looking for nimble, high-impact research collaborators.

Cross-Sell Potential Identify opportunities to expand into related precision oncology services, including functional genomics assays, companion diagnostics development, and data-driven trial design support, targeting partners pursuing next-gen targeted therapies and personalized medicine initiatives.